Guest guest Posted February 24, 2010 Report Share Posted February 24, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 24 Feb 2010 15:20:35 -0500 > > > > HCV ADVOCATE EBLAST > February 24 , 2010 > > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org. > > > > JOURNAL REVIEW > > Hepatitis Journal Review: Vol 7 no 2; February 2010 > by Liz Highleyman > In This Issue: > > Shorter Treatment for HCV Genotype 1? > HCV Found in Atherosclerosis Plaques > Kidney Disease in HIV/HCV Coinfection > Treatment of Injection Drug Users > Partial Immunity to HCV? > > > > DRUG PIPELINE > > Hepatitis C Treatments in Current Clinical Development - Updated February 15, 2010 > > > > FACT SHEETS > > Hepatitis B > > Easy B's > > Help with Medicines February 2010 > Medication Guide February 2010 > Taking HBV Medicines February 2010 > Herbs February 2010 > The Immune System February 2010 > Natural and Alternative Medicine February 2010 > Sleep February 2010 > Liver Cancer February 2010 > > > > Hepatitis C > > Easy C's > > New Hep C Medicines February 2010 > > Hepatitis C Basics > > Living with Hepatitis C: Managing Common Symptoms February 2010 > > Hepatitis Fact Series > > Tips for Lowering Prescription Drug Costs February 2010 > > > > Hepatitis C (Spanish) > > Datos Sencillos sobre la C > > ¿Qué es la Hepatitis C? (What is Hepatitis C?) Actualizado Febrero 2010 > Latinos (Latinos) Actualizado Febrero 2010 > Biopsia Hepática (Liver Biopsy) Actualizado Febrero 2010 > Dieta y Hepatitis C (Diet and Hepatitis C) Actualizado Febrero 2010 > Sueño y Hepatitis C (Sleep and Hepatitis C)Actualizado Febrero 2010 > Perforaciones Corporales y VHC (Piercing) Actualizado Febrero 2010 > Control de los Efectos Secundarios (Managing Side Effects) Actualizado Febrero 2010 > > > > Top 10 Downloads > > Top 10 HepB Downloads of the Month (February 2010) > Check out what everyone has been reading > > Top 10 HCV Downloads of the Month / Las 10 descargas más frecuentes del mes -- February 2010 > HCSP publishes a variety of Educational Materials which you can download and use in your community. Each month we will post the top 10 downloads of the month, for both English and Spanish. > > > > WEEKLY NEWS REVIEW > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: February 20, 2010 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Certain Syringes More Likely to Spread Hepatitis C Virus among Drug Users > Scioto County Ranks First in Hepatitis C Cases > Transfusion Victim Fights for Pay-Out > Survey of HBsAg-Positive Pregnant Women and Their Infants Regarding Measures to Prevent Maternal-Infantile Transmission > Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication > SHEA Releases Guidelines on Management of Healthcare Workers Infected with Hepatitis, HIV > Group Advocates Hepatitis C Education > Bill Would Ease Ban on Selling Syringes > Congress Considers Banning Medical Experiments on Chimpanzees > Pharmasset Announces Complete Enrollment of RG7128 Phase 2b Clinical Study > Dynavax Receives Canadian Approval to Conduct Phase 3 Trials of HEPLISAVT > FDA Warns of Maalox Mix-up Danger > Transplants Can Give Cirrhosis Patients a Brand-New Start, but Supply of Liver Donors Is Short > Guitar Legend Reveals Virus Shock > The Lack of Needles and the Damage Done > Clinic's Patients Warned of Hepatitis C Outbreak > Drug Diversion Needs More Compliance Attention; Hospital Technician Is Heading to Prison > 'Right to Know' Bill Would Impact Inmates with Diseases > > > > EVENTS > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 24, 2010 Report Share Posted February 24, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 24 Feb 2010 15:20:35 -0500 > > > > HCV ADVOCATE EBLAST > February 24 , 2010 > > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org. > > > > JOURNAL REVIEW > > Hepatitis Journal Review: Vol 7 no 2; February 2010 > by Liz Highleyman > In This Issue: > > Shorter Treatment for HCV Genotype 1? > HCV Found in Atherosclerosis Plaques > Kidney Disease in HIV/HCV Coinfection > Treatment of Injection Drug Users > Partial Immunity to HCV? > > > > DRUG PIPELINE > > Hepatitis C Treatments in Current Clinical Development - Updated February 15, 2010 > > > > FACT SHEETS > > Hepatitis B > > Easy B's > > Help with Medicines February 2010 > Medication Guide February 2010 > Taking HBV Medicines February 2010 > Herbs February 2010 > The Immune System February 2010 > Natural and Alternative Medicine February 2010 > Sleep February 2010 > Liver Cancer February 2010 > > > > Hepatitis C > > Easy C's > > New Hep C Medicines February 2010 > > Hepatitis C Basics > > Living with Hepatitis C: Managing Common Symptoms February 2010 > > Hepatitis Fact Series > > Tips for Lowering Prescription Drug Costs February 2010 > > > > Hepatitis C (Spanish) > > Datos Sencillos sobre la C > > ¿Qué es la Hepatitis C? (What is Hepatitis C?) Actualizado Febrero 2010 > Latinos (Latinos) Actualizado Febrero 2010 > Biopsia Hepática (Liver Biopsy) Actualizado Febrero 2010 > Dieta y Hepatitis C (Diet and Hepatitis C) Actualizado Febrero 2010 > Sueño y Hepatitis C (Sleep and Hepatitis C)Actualizado Febrero 2010 > Perforaciones Corporales y VHC (Piercing) Actualizado Febrero 2010 > Control de los Efectos Secundarios (Managing Side Effects) Actualizado Febrero 2010 > > > > Top 10 Downloads > > Top 10 HepB Downloads of the Month (February 2010) > Check out what everyone has been reading > > Top 10 HCV Downloads of the Month / Las 10 descargas más frecuentes del mes -- February 2010 > HCSP publishes a variety of Educational Materials which you can download and use in your community. Each month we will post the top 10 downloads of the month, for both English and Spanish. > > > > WEEKLY NEWS REVIEW > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: February 20, 2010 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Certain Syringes More Likely to Spread Hepatitis C Virus among Drug Users > Scioto County Ranks First in Hepatitis C Cases > Transfusion Victim Fights for Pay-Out > Survey of HBsAg-Positive Pregnant Women and Their Infants Regarding Measures to Prevent Maternal-Infantile Transmission > Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication > SHEA Releases Guidelines on Management of Healthcare Workers Infected with Hepatitis, HIV > Group Advocates Hepatitis C Education > Bill Would Ease Ban on Selling Syringes > Congress Considers Banning Medical Experiments on Chimpanzees > Pharmasset Announces Complete Enrollment of RG7128 Phase 2b Clinical Study > Dynavax Receives Canadian Approval to Conduct Phase 3 Trials of HEPLISAVT > FDA Warns of Maalox Mix-up Danger > Transplants Can Give Cirrhosis Patients a Brand-New Start, but Supply of Liver Donors Is Short > Guitar Legend Reveals Virus Shock > The Lack of Needles and the Damage Done > Clinic's Patients Warned of Hepatitis C Outbreak > Drug Diversion Needs More Compliance Attention; Hospital Technician Is Heading to Prison > 'Right to Know' Bill Would Impact Inmates with Diseases > > > > EVENTS > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 24, 2010 Report Share Posted February 24, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 24 Feb 2010 15:20:35 -0500 > > > > HCV ADVOCATE EBLAST > February 24 , 2010 > > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org. > > > > JOURNAL REVIEW > > Hepatitis Journal Review: Vol 7 no 2; February 2010 > by Liz Highleyman > In This Issue: > > Shorter Treatment for HCV Genotype 1? > HCV Found in Atherosclerosis Plaques > Kidney Disease in HIV/HCV Coinfection > Treatment of Injection Drug Users > Partial Immunity to HCV? > > > > DRUG PIPELINE > > Hepatitis C Treatments in Current Clinical Development - Updated February 15, 2010 > > > > FACT SHEETS > > Hepatitis B > > Easy B's > > Help with Medicines February 2010 > Medication Guide February 2010 > Taking HBV Medicines February 2010 > Herbs February 2010 > The Immune System February 2010 > Natural and Alternative Medicine February 2010 > Sleep February 2010 > Liver Cancer February 2010 > > > > Hepatitis C > > Easy C's > > New Hep C Medicines February 2010 > > Hepatitis C Basics > > Living with Hepatitis C: Managing Common Symptoms February 2010 > > Hepatitis Fact Series > > Tips for Lowering Prescription Drug Costs February 2010 > > > > Hepatitis C (Spanish) > > Datos Sencillos sobre la C > > ¿Qué es la Hepatitis C? (What is Hepatitis C?) Actualizado Febrero 2010 > Latinos (Latinos) Actualizado Febrero 2010 > Biopsia Hepática (Liver Biopsy) Actualizado Febrero 2010 > Dieta y Hepatitis C (Diet and Hepatitis C) Actualizado Febrero 2010 > Sueño y Hepatitis C (Sleep and Hepatitis C)Actualizado Febrero 2010 > Perforaciones Corporales y VHC (Piercing) Actualizado Febrero 2010 > Control de los Efectos Secundarios (Managing Side Effects) Actualizado Febrero 2010 > > > > Top 10 Downloads > > Top 10 HepB Downloads of the Month (February 2010) > Check out what everyone has been reading > > Top 10 HCV Downloads of the Month / Las 10 descargas más frecuentes del mes -- February 2010 > HCSP publishes a variety of Educational Materials which you can download and use in your community. Each month we will post the top 10 downloads of the month, for both English and Spanish. > > > > WEEKLY NEWS REVIEW > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: February 20, 2010 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Certain Syringes More Likely to Spread Hepatitis C Virus among Drug Users > Scioto County Ranks First in Hepatitis C Cases > Transfusion Victim Fights for Pay-Out > Survey of HBsAg-Positive Pregnant Women and Their Infants Regarding Measures to Prevent Maternal-Infantile Transmission > Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication > SHEA Releases Guidelines on Management of Healthcare Workers Infected with Hepatitis, HIV > Group Advocates Hepatitis C Education > Bill Would Ease Ban on Selling Syringes > Congress Considers Banning Medical Experiments on Chimpanzees > Pharmasset Announces Complete Enrollment of RG7128 Phase 2b Clinical Study > Dynavax Receives Canadian Approval to Conduct Phase 3 Trials of HEPLISAVT > FDA Warns of Maalox Mix-up Danger > Transplants Can Give Cirrhosis Patients a Brand-New Start, but Supply of Liver Donors Is Short > Guitar Legend Reveals Virus Shock > The Lack of Needles and the Damage Done > Clinic's Patients Warned of Hepatitis C Outbreak > Drug Diversion Needs More Compliance Attention; Hospital Technician Is Heading to Prison > 'Right to Know' Bill Would Impact Inmates with Diseases > > > > EVENTS > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 31, 2010 Report Share Posted March 31, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 31 Mar 2010 01:20:36 -0400 > > > > March 31, 2010 > > > > HCV » > HCV Advocate Newsletter, April 2010 > » > Hepatitis Journal Review March 2010 > » > News Review: March 27 > » > Action Alert H.R.3974 > » > New Videos > > > > Greetings from the HCV and HBV Advocate Websites: > We have recently posted many new articles, journals and the April 2010 HCV Advocate newsletter. Please click on the titles listed in the side bars to take you directly to the newly posted items on the HBV and HCV Advocate Websites. > As you know May is Hepatitis Awareness Month and May 19th is World Hepatitis Day. There will be many rallies and events during the month of May about viral hepatitis. Probably the most important one is going to be held in Washington D.C.: > Raise your voice: Are you angry that the government hasn't taken viral hepatitis seriously enough to fund it at an appropriate level? Do you want to give a voice to the viral hepatitis movement? If so, join us in Washington D.C. for a rally on May 19, 2010 to demand that Congress take notice and action of viral hepatitis. It's time that we raise our voices and be heard. For more information about the rally visit www.nvhr.org > . > Sincerely, > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... > **To receive the eblast in your email inbox simply send an e-mail to: listserv@... with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. > > > HBV » > HBV Journal Review: April 2010 > » > HBV Poster: Staying Healthy with Hepatitis B Updated > » > New: HBV Training Page > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 7, 2010 Report Share Posted April 7, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 7 Apr 2010 20:43:04 -0400 > > > > April 7, 2010 > > > > > HCV » > News Review: April 3, 2010 » > Updated: HCV Basics Factsheets » > Updated HCSP Russian Factsheets - ???????? ????????? ? ????? 2010 » > HCV Training Workshop Schedule » > Action Alert: Increased Funding > > > > Greetings from the HCV and HBV Advocate Websites: > Be sure to check out our updated popular HCV Basics Factsheets. This week we have updated the General Information and HCV Disease Progression sections. > As well, we have recently updated some Russian translations of our HCSP Factsheet Series. > ??????????? ?????????? ??? ??????? ??????????? ????????? ??????????? ?????????? > Also: remember to check the training pages on both the HCV and HBV Advocate websites to see what's coming to your area and to register early!!! > Finally: TAKE ACTION: Call Your Two Senators THIS MONTH to Support Increased Viral Hepatitis Prevention Funding. The deadline is April 16, so do it now. > . > Sincerely, > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... > **To receive the eblast in your email inbox simply send an e-mail to: listserv@... with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. > > > HBV » > HBV Training Workshop Schedule » > > HBV Poster: Staying Healthy with Hepatitis B Updated » > HBV Journal Review: April 2010 > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 2, 2010 Report Share Posted May 2, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Sun, 2 May 2010 21:38:23 -0400 > > > > May 2 , 2010 > > > > HCV » > HCV Advocate Newsletter: May 2010 » > Hepatitis Journal Review: April , 2010 » > Weekly News Review: May 1, 2010 » > HCV Drugs in Development: May 2, 2010 » > HCV Training Workshop Schedule > > > > Hello, > Spring is finally here and it's the perfect time to get outside, exercise, and make your voice heard. World Hepatitis Day is on May 19, 2010 and I hope you will join the hundreds of hepatitis advocates who will be in Washington D.C. to demand that the government finally fund hepatitis B and C. We need your voice! Click here for more info > On another advocacy note, we recently launched our national hepatitis B training workshops with seminars scheduled for Sacramento, CA on May 3, Philadelphia, PA on May 26, and Honolulu, Hawaii on June 30, 2010. A complete list of HCSP's HCV and HBV trainings are listed on our Websites. > We have many new items that have been posted to our HBV and HCV Websites including the May HCV Advocate newsletter, the weekly news review, the HCV and HBV Journal Review(s) as well as our updated HCV Drug Pipeline. > Hope to see you in D.C., > Alan > Join me on Twitter - > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 2, 2010 Report Share Posted May 2, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Sun, 2 May 2010 21:38:23 -0400 > > > > May 2 , 2010 > > > > HCV » > HCV Advocate Newsletter: May 2010 » > Hepatitis Journal Review: April , 2010 » > Weekly News Review: May 1, 2010 » > HCV Drugs in Development: May 2, 2010 » > HCV Training Workshop Schedule > > > > Hello, > Spring is finally here and it's the perfect time to get outside, exercise, and make your voice heard. World Hepatitis Day is on May 19, 2010 and I hope you will join the hundreds of hepatitis advocates who will be in Washington D.C. to demand that the government finally fund hepatitis B and C. We need your voice! Click here for more info > On another advocacy note, we recently launched our national hepatitis B training workshops with seminars scheduled for Sacramento, CA on May 3, Philadelphia, PA on May 26, and Honolulu, Hawaii on June 30, 2010. A complete list of HCSP's HCV and HBV trainings are listed on our Websites. > We have many new items that have been posted to our HBV and HCV Websites including the May HCV Advocate newsletter, the weekly news review, the HCV and HBV Journal Review(s) as well as our updated HCV Drug Pipeline. > Hope to see you in D.C., > Alan > Join me on Twitter - > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 25, 2010 Report Share Posted May 25, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 25 May 2010 19:01:52 -0400 > > > > May 25, 2010 > > > > HCV » > Weekly News Review: May 22, 2010 » > Top 10 HCV Downloads of the Month (May 24) » > Hepatitis Journal Review > > > > Hello: > Exciting news was released today about the phase III studies of telaprevir combination therapy. > The top-line results released list a 75% SVR in the group that received 12 weeks of telaprevir/ Pegasys/ribavirin (triple combo) followed by 12 weeks of Pegasys/ribavirin (without telaprevir) vs. a 44% SVR in the group that was treated for 48 weeks with Pegasys/ribavirin (without telaprevir). > In another arm of the trial, people who received just 8 weeks of triple therapy followed by Pegasys/ribavirin achieved an SVR of 69%. > See Vertex's press release for more information. > We have also posted the Hepatitis Journal Review, our Weekly News Review, the Top 10 Downloads of the Month for the HBV Advocate and HCV Advocate Web sites and updated our Guide to Hepatitis B. > > Cheers, > Alan > Join me on Twitter - > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 25, 2010 Report Share Posted May 25, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 25 May 2010 19:01:52 -0400 > > > > May 25, 2010 > > > > HCV » > Weekly News Review: May 22, 2010 » > Top 10 HCV Downloads of the Month (May 24) » > Hepatitis Journal Review > > > > Hello: > Exciting news was released today about the phase III studies of telaprevir combination therapy. > The top-line results released list a 75% SVR in the group that received 12 weeks of telaprevir/ Pegasys/ribavirin (triple combo) followed by 12 weeks of Pegasys/ribavirin (without telaprevir) vs. a 44% SVR in the group that was treated for 48 weeks with Pegasys/ribavirin (without telaprevir). > In another arm of the trial, people who received just 8 weeks of triple therapy followed by Pegasys/ribavirin achieved an SVR of 69%. > See Vertex's press release for more information. > We have also posted the Hepatitis Journal Review, our Weekly News Review, the Top 10 Downloads of the Month for the HBV Advocate and HCV Advocate Web sites and updated our Guide to Hepatitis B. > > Cheers, > Alan > Join me on Twitter - > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 25, 2010 Report Share Posted May 25, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 25 May 2010 19:01:52 -0400 > > > > May 25, 2010 > > > > HCV » > Weekly News Review: May 22, 2010 » > Top 10 HCV Downloads of the Month (May 24) » > Hepatitis Journal Review > > > > Hello: > Exciting news was released today about the phase III studies of telaprevir combination therapy. > The top-line results released list a 75% SVR in the group that received 12 weeks of telaprevir/ Pegasys/ribavirin (triple combo) followed by 12 weeks of Pegasys/ribavirin (without telaprevir) vs. a 44% SVR in the group that was treated for 48 weeks with Pegasys/ribavirin (without telaprevir). > In another arm of the trial, people who received just 8 weeks of triple therapy followed by Pegasys/ribavirin achieved an SVR of 69%. > See Vertex's press release for more information. > We have also posted the Hepatitis Journal Review, our Weekly News Review, the Top 10 Downloads of the Month for the HBV Advocate and HCV Advocate Web sites and updated our Guide to Hepatitis B. > > Cheers, > Alan > Join me on Twitter - > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 25, 2010 Report Share Posted May 25, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 25 May 2010 19:01:52 -0400 > > > > May 25, 2010 > > > > HCV » > Weekly News Review: May 22, 2010 » > Top 10 HCV Downloads of the Month (May 24) » > Hepatitis Journal Review > > > > Hello: > Exciting news was released today about the phase III studies of telaprevir combination therapy. > The top-line results released list a 75% SVR in the group that received 12 weeks of telaprevir/ Pegasys/ribavirin (triple combo) followed by 12 weeks of Pegasys/ribavirin (without telaprevir) vs. a 44% SVR in the group that was treated for 48 weeks with Pegasys/ribavirin (without telaprevir). > In another arm of the trial, people who received just 8 weeks of triple therapy followed by Pegasys/ribavirin achieved an SVR of 69%. > See Vertex's press release for more information. > We have also posted the Hepatitis Journal Review, our Weekly News Review, the Top 10 Downloads of the Month for the HBV Advocate and HCV Advocate Web sites and updated our Guide to Hepatitis B. > > Cheers, > Alan > Join me on Twitter - > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 13, 2010 Report Share Posted June 13, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Fri, 11 Jun 2010 17:54:29 -0400 > > > > June 11, 2010 > > > > HCV » > Weekly News Review: June 5, 2010 » > HCV Drug Pipeline Updated June 3, 2010 » > Weekly News Review: June 5, 2010 > > > > > Hello: > This week we have updated many of our Mental Health and Wellness series hepatitis C fact sheets, as well as our Drug Pipeline. > We have also updated one of our most in demand brohcures --The Liver - The Basics, which can be ordered free of charge by clicking on any of these links HCV Educational Materials, HBV Educational Materials. > Finally, be sure to check out our Weekly News Review to catch up on the latest news and information about HBV, HCV and HIV and hepatitis coinfections. > > Cheers, > Alan > Join me on Twitter - > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 15, 2010 Report Share Posted July 15, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 14 Jul 2010 14:46:38 -0400 > > > > July 14, 2010 > > > > HCV » > HCV Drug Pipeline: Updated July 14, 2010 » > Action Alert » > HCSP Guides » > Weekly News Review: July 10, 2010 > > > > > Hello, > In this week's Eblast we have some very exciting new postings. > First is the updated HCV Drug Pipeline that has information on TMC 436, a HCV protease inhibitor (in combination with pegylated interferon plus ribavirin) that showed fantastic interim results in a phase II study. > It will be interesting to see if the final results of this study show the same trend. Of course, the study is too small to give us all the information we need but hopefully this positive data will help to push the triple combo forward into phase III study. > Another noteworthy item we posted was an Action Alert to get people to contact their representative to support an increase of up to $50 million for viral hepatitis prevention. Make yourself heard and hopefully we can get more funding for viral hepartitis. > We also have our News Review that was posted on Saturday as well as many HCSP Guides have been reviewed and updated to reflect the newest information about our understanding of various topics. > Sincerely, > Alan > > Join me on Twitter - > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 15, 2010 Report Share Posted July 15, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 14 Jul 2010 14:46:38 -0400 > > > > July 14, 2010 > > > > HCV » > HCV Drug Pipeline: Updated July 14, 2010 » > Action Alert » > HCSP Guides » > Weekly News Review: July 10, 2010 > > > > > Hello, > In this week's Eblast we have some very exciting new postings. > First is the updated HCV Drug Pipeline that has information on TMC 436, a HCV protease inhibitor (in combination with pegylated interferon plus ribavirin) that showed fantastic interim results in a phase II study. > It will be interesting to see if the final results of this study show the same trend. Of course, the study is too small to give us all the information we need but hopefully this positive data will help to push the triple combo forward into phase III study. > Another noteworthy item we posted was an Action Alert to get people to contact their representative to support an increase of up to $50 million for viral hepatitis prevention. Make yourself heard and hopefully we can get more funding for viral hepartitis. > We also have our News Review that was posted on Saturday as well as many HCSP Guides have been reviewed and updated to reflect the newest information about our understanding of various topics. > Sincerely, > Alan > > Join me on Twitter - > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 2, 2010 Report Share Posted August 2, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Mon, 2 Aug 2010 21:33:18 -0400 > > > > August 2, 2010 > > > > HCV » > HCV Advocate Newsletter, August 2010 » > HBV & HCV Advocate Hepatitis Blog » > Hepatitis C and HIV/HCV Coinfection Powerpoint » > Drug Pipeline: Updated July 30 » > Weekly News Review: July 31, 2010 > > > > Hello everyone, > It's been another busy month at the HCV and HBV Advocate. The following items have been recently posted: > 1. HCV Advocate Newsletter, August 2010 > In This Issue: > > Read about the important new approval and discoveries regarding HCV diagnostic tools: > Advances in HCV Diagnostics: OraQuick® HCV Rapid Antibody Test; The Bisosensor > Alan Franciscus, Editor-in-Chief > If you are lucky enough to have two health insurance policies this month's Benefits Column is a must read: > Disability & Benefits: Coverage Under Multiple Health Plans > Jacques Chambers, CLU > Best intentions are sometimes not always understood. " You look so good " can often be interpreted poorly by someone with hepatitis C. Read Lucinda's take on this: > HealthWise: Words that Wound, Words that Heal > Lucinda Porter, RN > Research is yielding some amazing tools to predict treatment response. Read about a variation in IL28B that 'predicts' treatment success in people with HCV genotype 1: > The Gene that Predicts > Alan Franciscus, Editor-in-Chief > 2. HBV and HCV Blog > We just launched our HBV and HCV Blog. We plan to use this blog to answer some of the questions that our website and training audiences ask. We already have about 4 items-from various abstracts to general questions-that need to be answered. We welcome comments from our audience-we just ask that you don't ask personal health questions because we are not medical providers! > Blog http://hcvadvocate.blogspot.com/ > 3. HBV Journal Review > M. Kukka reviews important news and journal articles regarding HBV treatment, disease progression, vaccination and more.... > HBV Journal Review: August 1, 2010, Vol 7, no 8 > 4. Weekly News Review - The best of the news on HCV, HBV and HIV and hepatitis coinfections > Week Ending July 31, 2010 > 5. Hepatitis C and HIV/HCV Coinfection - This is the entire slide presentation that I used last week to present to the Montana HIV Community Planning Group. > http://www.hcvadvocate.org/Training/HIV%20 > HCV%20Coinfection%202010.ppt > > Join me on Twitter - > > > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 2, 2010 Report Share Posted August 2, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Mon, 2 Aug 2010 21:33:18 -0400 > > > > August 2, 2010 > > > > HCV » > HCV Advocate Newsletter, August 2010 » > HBV & HCV Advocate Hepatitis Blog » > Hepatitis C and HIV/HCV Coinfection Powerpoint » > Drug Pipeline: Updated July 30 » > Weekly News Review: July 31, 2010 > > > > Hello everyone, > It's been another busy month at the HCV and HBV Advocate. The following items have been recently posted: > 1. HCV Advocate Newsletter, August 2010 > In This Issue: > > Read about the important new approval and discoveries regarding HCV diagnostic tools: > Advances in HCV Diagnostics: OraQuick® HCV Rapid Antibody Test; The Bisosensor > Alan Franciscus, Editor-in-Chief > If you are lucky enough to have two health insurance policies this month's Benefits Column is a must read: > Disability & Benefits: Coverage Under Multiple Health Plans > Jacques Chambers, CLU > Best intentions are sometimes not always understood. " You look so good " can often be interpreted poorly by someone with hepatitis C. Read Lucinda's take on this: > HealthWise: Words that Wound, Words that Heal > Lucinda Porter, RN > Research is yielding some amazing tools to predict treatment response. Read about a variation in IL28B that 'predicts' treatment success in people with HCV genotype 1: > The Gene that Predicts > Alan Franciscus, Editor-in-Chief > 2. HBV and HCV Blog > We just launched our HBV and HCV Blog. We plan to use this blog to answer some of the questions that our website and training audiences ask. We already have about 4 items-from various abstracts to general questions-that need to be answered. We welcome comments from our audience-we just ask that you don't ask personal health questions because we are not medical providers! > Blog http://hcvadvocate.blogspot.com/ > 3. HBV Journal Review > M. Kukka reviews important news and journal articles regarding HBV treatment, disease progression, vaccination and more.... > HBV Journal Review: August 1, 2010, Vol 7, no 8 > 4. Weekly News Review - The best of the news on HCV, HBV and HIV and hepatitis coinfections > Week Ending July 31, 2010 > 5. Hepatitis C and HIV/HCV Coinfection - This is the entire slide presentation that I used last week to present to the Montana HIV Community Planning Group. > http://www.hcvadvocate.org/Training/HIV%20 > HCV%20Coinfection%202010.ppt > > Join me on Twitter - > > > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2010 Report Share Posted August 22, 2010 If you have time watch Zirbes' presentation, a bit long but good info. The Drug Pipeline update is worth a read for those who are 'Watchful Waiting'. > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Sun, 22 Aug 2010 23:54:02 -0400 > > > > August 22, 2010 > > > > HCV » > Zirbes on " Stigma " » > Life Management During HCV Treatment » > Your Doctor and Disability Support Letters » > Top 10 HCV Downloads » > Drug Pipeline: Updated August 16 » > Weekly News Review: August 21, 2010 > > > > Hello: > This week's postings include the following topics: > 1. From the Minnesota Viral Hepatitis Conference: Z of " 's Lot " talks about her efforts to raise awareness of hepatitis C and about the Stigma associated with hepatitis C. This is a very powerful video that I encourage you to share with your family and friends to help educate them on some of the issues we face in our everyday lives. Also, the slides from my presentation " Life Management During HCV Treatment " have been uploaded to our Trainer's page. > 2. The monthly Benefits Column by Jacques Chambers features an article about working with your medical provider to make sure your medical records contain the necessary information if you should ever need to file a disability claim or if you are filing the claim now. The article is titled " Your Doctor and Disability Support Letters. " > 3. The " Top 10 Downloads " from the HCV and HBV Advocate Web sites - find out what others are reading on our websites. > 4. The Weekly News Review that has the top news stories on HCV, HBV and HIV and hepatitis coinfections. > 5. Rounding out the postings we updated the HCV Drug Pipeline which now includes top-line results from the boceprevir and telaprevir phase III studies. > > To watch a video version of this eblast click here > > Join me on Twitter - > > > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 30, 2010 Report Share Posted September 30, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Thu, 30 Sep 2010 19:37:55 -0400 > > > > September 30, 2010 > > > > > HCV » > Updated Easy C Fact Sheets » > Updated HCV Basics Fact Sheets » > Updated FAQ's » > HCSP Streaming Videos » > Top 10 HCV Downloads » > Hepatitis A: What You Need to Know > > > > > Dear Readers, > Thank you for taking the time out of your busy day to read this Eblast. I wanted to make you aware of the new items we have uploaded to our HBV and HCV Advocate Websites: > > October 2010 HCV Advocate Newsletter: > > REALIZE: Top-line results from the phase III trial of telaprevir, pegylated interferon and ribavirin to treat people who did not achieve an SVR with a previous course of pegylated interferon and ribavirin. You can also join me on-line for an HCV Advocate Video Update on the trial results. > > Disability and Benefits: Life Settlements (Cash for Your Life Insurance Policy) - read about the various types of life settlements, information about the potential benefits and downsides to cash in on insurance. > > > HealthWise: Finding Safety in Numbers by Lucinda Porter who discusses the changing landscape of HCV disease progression and some thoughts about what it means > > > HCV Snapshots - short recaps of some interesting studies about hepatitis C > > > SVR Reduces Risk of Death and Disease: Read about the very encouraging news about the benefits of achieving an SVR and even the benefits of just going HCV RNA undetectable while on HCV therapy. > > HBV Journal Review: > > Read about various issues and outcomes of HBV treatment, HBV transmission, Immunizations strategies, articles and other important information about HBV. > > Be sure to check out the Herbal Dietary Supplements Glossary that we recently reviewed and updated. > > Sincerely, > Alan > > > Join me on Twitter - > > > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate www.hcvadvocate.org > Editor-in-Chief, HBV Advocate www.hbvadvocate.org > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 20, 2011 Report Share Posted February 20, 2011 -------- Begin forwarded message -------- Subject: HCV Advocate Email Alert Date: 2/20/11 6:02:38 PM From: " www.hcvadvocate.org " emailalert@... February 21, 2011 HCV & raquo; February Newsletter <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> & raquo; HCV Fact Sheets <http://www.hcvadvocate.org/hepatitis/factsheets.asp> <http://www.hcvadvocate.org/hepatitis/factsheets.asp> & raquo; Educational Materials <http://www.hcvadvocate.org/hepatitis/materials.asp> <http://www.hcvadvocate.org/hepatitis/materials.asp> & raquo; HCSP Streaming Videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> Greetings: <http://www.hcvadvocate.org/hepatitis/training_resources.asp> This was another incredible week with news about hepatitis C. The most important news item was the press release from Tibotec <http://hcvadvocate.blogspot.com/2011/02/tibotec-starts-global-phase-3-clinical.\ html> announcing the start of phase III studies of their once-a-day dose of TMC-435-an HCV protease inhibitor. Stay tuned for information about this drug - in addition to the once-a-day dosing the preliminary data from the phase II studies looks very promising. <http://hcvadvocate.blogspot.com/2011/02/tibotec-starts-global-phase-3-clinical.\ html> 2. In addition to the Tibotec news you might want to check out what others are reading about hepatitis B and hepatitis C. The Top Ten English and Spanish fact sheets <http://www.hcvadvocate.org/hepatitis/Top_Dwnloads_Feb20_11.asp> include Acetaminophen and Your Liver , Short Term Disability , and more. On the HBV Advocate the Top <http://www.hbvadvocate.org/hepatitis/B%20top10%20%20Feb20_11.asp> Ten includes How to Interpret Hepatitis B Antibody and Viral Tests , Hepatitis B Antigen and Antibody Tests and many more. <http://www.hbvadvocate.org/hepatitis/B%20top10%20%20Feb20_11.asp> 3. Jacques Chambers monthly column is on " Taxation of Disability Benefits <http://www.hcvadvocate.org/hepatitis/hepC/Taxation%20of%20Disability%20Benefits\ _2011.html> " - a must read if you are paying into disability and want to make sure you are reporting the income correctly. <http://www.hcvadvocate.org/hepatitis/hepC/Taxation%20of%20Disability%20Benefits\ _2011.html> 4. Centerforce <http://www.centerforce.org/> in cooperation with San Quentin and prison peer educators have produced three videos titled " Mythbusters, which you can find on our Patient Education page under streaming videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> . " Feel free to pass these around to other prisons that are educating peers about hepatitis C. <http://www.hcvadvocate.org/hepatitis/training_resources.asp> 5. Our HCSP Training Calendar <http://www.hcvadvocate.org/hepatitis/hepC/commforum.html> has been updated through April 2011. If you are interested in attending one of our trainings the flyers will soon be available for the confirmed dates and locations so that you can find out more information on how to register. <http://www.hcvadvocate.org/hepatitis/hepC/commforum.html> 6. Lastly, the CDC in cooperation with AASLD is sponsoring a Hepatitis Single Topic Conference on June 4-5, 2011 in Atlanta, GA. The conference topic is " Chronic Viral Hepatitis Strategies to Improve Effectiveness of Screening and Treatment <http://www.hcvadvocate.org/community/events.asp> . " <http://www.hcvadvocate.org/community/events.asp> <http://www.hcvadvocate.org/community/events.asp> Don't forget to keep checking out our blog <http://hcvadvocate.blogspot.com/> for more about the most recent news stories. <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Sincerely, Alan <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Join us on Twitter - <http://twitter.com/HCVAdvocate> . <http://twitter.com/HCVAdvocate> Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.org <http://www.hcvadvocate.org> Editor-in-Chief, HBV Advocate www.hbvadvocate.org <http://www.hbvadvocate.org> <http://www.hbvadvocate.org> .. <http://www.hbvadvocate.org> **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> **To receive the eblast in your email inbox simply send an e-mail to: listserv@... <javascript:parent.gMail.openComposeWindow('listserv@...')> with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. <javascript:parent.gMail.openComposeWindow('listserv@...')> .. <javascript:parent.gMail.openComposeWindow('listserv@...')> <http://www.hcvadvocate.org/index.asp> HBV & raquo; HBV Journal Review <http://www.hbvadvocate.org/news/HBJ8.2.htm> <http://www.hbvadvocate.org/news/HBJ8.2.htm> & raquo; HBV Factsheets <http://www.hbvadvocate.org/hepatitis/factsheets.asp> <http://www.hbvadvocate.org/hepatitis/factsheets.asp> & raquo; HBV & HCV Advocate Hepatitis Blog <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> & raquo; Stay connected with all the late-breaking news on hepatitis B <http://twitter.com/HBVAdvocate> -Join us on Twitter <http://twitter.com/HBVAdvocate> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 20, 2011 Report Share Posted February 20, 2011 -------- Begin forwarded message -------- Subject: HCV Advocate Email Alert Date: 2/20/11 6:02:38 PM From: " www.hcvadvocate.org " emailalert@... February 21, 2011 HCV & raquo; February Newsletter <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> & raquo; HCV Fact Sheets <http://www.hcvadvocate.org/hepatitis/factsheets.asp> <http://www.hcvadvocate.org/hepatitis/factsheets.asp> & raquo; Educational Materials <http://www.hcvadvocate.org/hepatitis/materials.asp> <http://www.hcvadvocate.org/hepatitis/materials.asp> & raquo; HCSP Streaming Videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> Greetings: <http://www.hcvadvocate.org/hepatitis/training_resources.asp> This was another incredible week with news about hepatitis C. The most important news item was the press release from Tibotec <http://hcvadvocate.blogspot.com/2011/02/tibotec-starts-global-phase-3-clinical.\ html> announcing the start of phase III studies of their once-a-day dose of TMC-435-an HCV protease inhibitor. Stay tuned for information about this drug - in addition to the once-a-day dosing the preliminary data from the phase II studies looks very promising. <http://hcvadvocate.blogspot.com/2011/02/tibotec-starts-global-phase-3-clinical.\ html> 2. In addition to the Tibotec news you might want to check out what others are reading about hepatitis B and hepatitis C. The Top Ten English and Spanish fact sheets <http://www.hcvadvocate.org/hepatitis/Top_Dwnloads_Feb20_11.asp> include Acetaminophen and Your Liver , Short Term Disability , and more. On the HBV Advocate the Top <http://www.hbvadvocate.org/hepatitis/B%20top10%20%20Feb20_11.asp> Ten includes How to Interpret Hepatitis B Antibody and Viral Tests , Hepatitis B Antigen and Antibody Tests and many more. <http://www.hbvadvocate.org/hepatitis/B%20top10%20%20Feb20_11.asp> 3. Jacques Chambers monthly column is on " Taxation of Disability Benefits <http://www.hcvadvocate.org/hepatitis/hepC/Taxation%20of%20Disability%20Benefits\ _2011.html> " - a must read if you are paying into disability and want to make sure you are reporting the income correctly. <http://www.hcvadvocate.org/hepatitis/hepC/Taxation%20of%20Disability%20Benefits\ _2011.html> 4. Centerforce <http://www.centerforce.org/> in cooperation with San Quentin and prison peer educators have produced three videos titled " Mythbusters, which you can find on our Patient Education page under streaming videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> . " Feel free to pass these around to other prisons that are educating peers about hepatitis C. <http://www.hcvadvocate.org/hepatitis/training_resources.asp> 5. Our HCSP Training Calendar <http://www.hcvadvocate.org/hepatitis/hepC/commforum.html> has been updated through April 2011. If you are interested in attending one of our trainings the flyers will soon be available for the confirmed dates and locations so that you can find out more information on how to register. <http://www.hcvadvocate.org/hepatitis/hepC/commforum.html> 6. Lastly, the CDC in cooperation with AASLD is sponsoring a Hepatitis Single Topic Conference on June 4-5, 2011 in Atlanta, GA. The conference topic is " Chronic Viral Hepatitis Strategies to Improve Effectiveness of Screening and Treatment <http://www.hcvadvocate.org/community/events.asp> . " <http://www.hcvadvocate.org/community/events.asp> <http://www.hcvadvocate.org/community/events.asp> Don't forget to keep checking out our blog <http://hcvadvocate.blogspot.com/> for more about the most recent news stories. <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Sincerely, Alan <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Join us on Twitter - <http://twitter.com/HCVAdvocate> . <http://twitter.com/HCVAdvocate> Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.org <http://www.hcvadvocate.org> Editor-in-Chief, HBV Advocate www.hbvadvocate.org <http://www.hbvadvocate.org> <http://www.hbvadvocate.org> .. <http://www.hbvadvocate.org> **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> **To receive the eblast in your email inbox simply send an e-mail to: listserv@... <javascript:parent.gMail.openComposeWindow('listserv@...')> with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. <javascript:parent.gMail.openComposeWindow('listserv@...')> .. <javascript:parent.gMail.openComposeWindow('listserv@...')> <http://www.hcvadvocate.org/index.asp> HBV & raquo; HBV Journal Review <http://www.hbvadvocate.org/news/HBJ8.2.htm> <http://www.hbvadvocate.org/news/HBJ8.2.htm> & raquo; HBV Factsheets <http://www.hbvadvocate.org/hepatitis/factsheets.asp> <http://www.hbvadvocate.org/hepatitis/factsheets.asp> & raquo; HBV & HCV Advocate Hepatitis Blog <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> & raquo; Stay connected with all the late-breaking news on hepatitis B <http://twitter.com/HBVAdvocate> -Join us on Twitter <http://twitter.com/HBVAdvocate> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 20, 2011 Report Share Posted February 20, 2011 -------- Begin forwarded message -------- Subject: HCV Advocate Email Alert Date: 2/20/11 6:02:38 PM From: " www.hcvadvocate.org " emailalert@... February 21, 2011 HCV & raquo; February Newsletter <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> & raquo; HCV Fact Sheets <http://www.hcvadvocate.org/hepatitis/factsheets.asp> <http://www.hcvadvocate.org/hepatitis/factsheets.asp> & raquo; Educational Materials <http://www.hcvadvocate.org/hepatitis/materials.asp> <http://www.hcvadvocate.org/hepatitis/materials.asp> & raquo; HCSP Streaming Videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> Greetings: <http://www.hcvadvocate.org/hepatitis/training_resources.asp> This was another incredible week with news about hepatitis C. The most important news item was the press release from Tibotec <http://hcvadvocate.blogspot.com/2011/02/tibotec-starts-global-phase-3-clinical.\ html> announcing the start of phase III studies of their once-a-day dose of TMC-435-an HCV protease inhibitor. Stay tuned for information about this drug - in addition to the once-a-day dosing the preliminary data from the phase II studies looks very promising. <http://hcvadvocate.blogspot.com/2011/02/tibotec-starts-global-phase-3-clinical.\ html> 2. In addition to the Tibotec news you might want to check out what others are reading about hepatitis B and hepatitis C. The Top Ten English and Spanish fact sheets <http://www.hcvadvocate.org/hepatitis/Top_Dwnloads_Feb20_11.asp> include Acetaminophen and Your Liver , Short Term Disability , and more. On the HBV Advocate the Top <http://www.hbvadvocate.org/hepatitis/B%20top10%20%20Feb20_11.asp> Ten includes How to Interpret Hepatitis B Antibody and Viral Tests , Hepatitis B Antigen and Antibody Tests and many more. <http://www.hbvadvocate.org/hepatitis/B%20top10%20%20Feb20_11.asp> 3. Jacques Chambers monthly column is on " Taxation of Disability Benefits <http://www.hcvadvocate.org/hepatitis/hepC/Taxation%20of%20Disability%20Benefits\ _2011.html> " - a must read if you are paying into disability and want to make sure you are reporting the income correctly. <http://www.hcvadvocate.org/hepatitis/hepC/Taxation%20of%20Disability%20Benefits\ _2011.html> 4. Centerforce <http://www.centerforce.org/> in cooperation with San Quentin and prison peer educators have produced three videos titled " Mythbusters, which you can find on our Patient Education page under streaming videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> . " Feel free to pass these around to other prisons that are educating peers about hepatitis C. <http://www.hcvadvocate.org/hepatitis/training_resources.asp> 5. Our HCSP Training Calendar <http://www.hcvadvocate.org/hepatitis/hepC/commforum.html> has been updated through April 2011. If you are interested in attending one of our trainings the flyers will soon be available for the confirmed dates and locations so that you can find out more information on how to register. <http://www.hcvadvocate.org/hepatitis/hepC/commforum.html> 6. Lastly, the CDC in cooperation with AASLD is sponsoring a Hepatitis Single Topic Conference on June 4-5, 2011 in Atlanta, GA. The conference topic is " Chronic Viral Hepatitis Strategies to Improve Effectiveness of Screening and Treatment <http://www.hcvadvocate.org/community/events.asp> . " <http://www.hcvadvocate.org/community/events.asp> <http://www.hcvadvocate.org/community/events.asp> Don't forget to keep checking out our blog <http://hcvadvocate.blogspot.com/> for more about the most recent news stories. <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Sincerely, Alan <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Join us on Twitter - <http://twitter.com/HCVAdvocate> . <http://twitter.com/HCVAdvocate> Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.org <http://www.hcvadvocate.org> Editor-in-Chief, HBV Advocate www.hbvadvocate.org <http://www.hbvadvocate.org> <http://www.hbvadvocate.org> .. <http://www.hbvadvocate.org> **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> **To receive the eblast in your email inbox simply send an e-mail to: listserv@... <javascript:parent.gMail.openComposeWindow('listserv@...')> with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. <javascript:parent.gMail.openComposeWindow('listserv@...')> .. <javascript:parent.gMail.openComposeWindow('listserv@...')> <http://www.hcvadvocate.org/index.asp> HBV & raquo; HBV Journal Review <http://www.hbvadvocate.org/news/HBJ8.2.htm> <http://www.hbvadvocate.org/news/HBJ8.2.htm> & raquo; HBV Factsheets <http://www.hbvadvocate.org/hepatitis/factsheets.asp> <http://www.hbvadvocate.org/hepatitis/factsheets.asp> & raquo; HBV & HCV Advocate Hepatitis Blog <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> & raquo; Stay connected with all the late-breaking news on hepatitis B <http://twitter.com/HBVAdvocate> -Join us on Twitter <http://twitter.com/HBVAdvocate> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 20, 2011 Report Share Posted February 20, 2011 -------- Begin forwarded message -------- Subject: HCV Advocate Email Alert Date: 2/20/11 6:02:38 PM From: " www.hcvadvocate.org " emailalert@... February 21, 2011 HCV & raquo; February Newsletter <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> & raquo; HCV Fact Sheets <http://www.hcvadvocate.org/hepatitis/factsheets.asp> <http://www.hcvadvocate.org/hepatitis/factsheets.asp> & raquo; Educational Materials <http://www.hcvadvocate.org/hepatitis/materials.asp> <http://www.hcvadvocate.org/hepatitis/materials.asp> & raquo; HCSP Streaming Videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> Greetings: <http://www.hcvadvocate.org/hepatitis/training_resources.asp> This was another incredible week with news about hepatitis C. The most important news item was the press release from Tibotec <http://hcvadvocate.blogspot.com/2011/02/tibotec-starts-global-phase-3-clinical.\ html> announcing the start of phase III studies of their once-a-day dose of TMC-435-an HCV protease inhibitor. Stay tuned for information about this drug - in addition to the once-a-day dosing the preliminary data from the phase II studies looks very promising. <http://hcvadvocate.blogspot.com/2011/02/tibotec-starts-global-phase-3-clinical.\ html> 2. In addition to the Tibotec news you might want to check out what others are reading about hepatitis B and hepatitis C. The Top Ten English and Spanish fact sheets <http://www.hcvadvocate.org/hepatitis/Top_Dwnloads_Feb20_11.asp> include Acetaminophen and Your Liver , Short Term Disability , and more. On the HBV Advocate the Top <http://www.hbvadvocate.org/hepatitis/B%20top10%20%20Feb20_11.asp> Ten includes How to Interpret Hepatitis B Antibody and Viral Tests , Hepatitis B Antigen and Antibody Tests and many more. <http://www.hbvadvocate.org/hepatitis/B%20top10%20%20Feb20_11.asp> 3. Jacques Chambers monthly column is on " Taxation of Disability Benefits <http://www.hcvadvocate.org/hepatitis/hepC/Taxation%20of%20Disability%20Benefits\ _2011.html> " - a must read if you are paying into disability and want to make sure you are reporting the income correctly. <http://www.hcvadvocate.org/hepatitis/hepC/Taxation%20of%20Disability%20Benefits\ _2011.html> 4. Centerforce <http://www.centerforce.org/> in cooperation with San Quentin and prison peer educators have produced three videos titled " Mythbusters, which you can find on our Patient Education page under streaming videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> . " Feel free to pass these around to other prisons that are educating peers about hepatitis C. <http://www.hcvadvocate.org/hepatitis/training_resources.asp> 5. Our HCSP Training Calendar <http://www.hcvadvocate.org/hepatitis/hepC/commforum.html> has been updated through April 2011. If you are interested in attending one of our trainings the flyers will soon be available for the confirmed dates and locations so that you can find out more information on how to register. <http://www.hcvadvocate.org/hepatitis/hepC/commforum.html> 6. Lastly, the CDC in cooperation with AASLD is sponsoring a Hepatitis Single Topic Conference on June 4-5, 2011 in Atlanta, GA. The conference topic is " Chronic Viral Hepatitis Strategies to Improve Effectiveness of Screening and Treatment <http://www.hcvadvocate.org/community/events.asp> . " <http://www.hcvadvocate.org/community/events.asp> <http://www.hcvadvocate.org/community/events.asp> Don't forget to keep checking out our blog <http://hcvadvocate.blogspot.com/> for more about the most recent news stories. <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Sincerely, Alan <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Join us on Twitter - <http://twitter.com/HCVAdvocate> . <http://twitter.com/HCVAdvocate> Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.org <http://www.hcvadvocate.org> Editor-in-Chief, HBV Advocate www.hbvadvocate.org <http://www.hbvadvocate.org> <http://www.hbvadvocate.org> .. <http://www.hbvadvocate.org> **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> **To receive the eblast in your email inbox simply send an e-mail to: listserv@... <javascript:parent.gMail.openComposeWindow('listserv@...')> with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. <javascript:parent.gMail.openComposeWindow('listserv@...')> .. <javascript:parent.gMail.openComposeWindow('listserv@...')> <http://www.hcvadvocate.org/index.asp> HBV & raquo; HBV Journal Review <http://www.hbvadvocate.org/news/HBJ8.2.htm> <http://www.hbvadvocate.org/news/HBJ8.2.htm> & raquo; HBV Factsheets <http://www.hbvadvocate.org/hepatitis/factsheets.asp> <http://www.hbvadvocate.org/hepatitis/factsheets.asp> & raquo; HBV & HCV Advocate Hepatitis Blog <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> & raquo; Stay connected with all the late-breaking news on hepatitis B <http://twitter.com/HBVAdvocate> -Join us on Twitter <http://twitter.com/HBVAdvocate> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 1, 2011 Report Share Posted March 1, 2011 -------- Begin forwarded message -------- Subject: HCV Advocate Email Alert Date: 3/1/11 11:53:54 AM From: " www.hcvadvocate.org " emailalert@... March 1, 2011 HCV & raquo; February Newsletter <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> & raquo; HCV Fact Sheets <http://www.hcvadvocate.org/hepatitis/factsheets.asp> <http://www.hcvadvocate.org/hepatitis/factsheets.asp> & raquo; Educational Materials <http://www.hcvadvocate.org/hepatitis/materials.asp> <http://www.hcvadvocate.org/hepatitis/materials.asp> & raquo; HCSP Streaming Videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> Hello: <http://www.hcvadvocate.org/hepatitis/training_resources.asp> I am Kukka, HBV Project Manager with the Hepatitis C Support Project (HCSP). Every month, I scour dozens of medical journals to find out the latest about hepatitis B treatment and disease progression and prevention. The type of reports I look for can range from a study on a successful community approach to screening and immunizing immigrants against hepatitis B, to an analysis that identifies which patients would benefit most from pegylated interferon. <http://www.hcvadvocate.org/hepatitis/training_resources.asp> 1. In this month's HBV Journal Review <http://www.hbvadvocate.org/news/HBJ8.3.htm> , posted at the HCSP HBV dedicated site, the HBV Advocate <http://www.hbvadvocate.org> , readers can learn about how lives and health care dollars are saved when treatment begins early, how in vitro fertilization can transmit HBV, and how doctors lack clear guidelines about when it's safe for patients to stop antiviral treatment. <http://www.hbvadvocate.org> <http://www.hbvadvocate.org> 2. Also... be sure to check out the HCV Advocate <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> Newsletter <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> for the month of March, 2011. <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> In This Issue: <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> HCV Protease Inhibitor-TMC435: Phase 3 Studies Alan Franciscus, Editor-in-Chief Hepatitis C in Egypt Alan Franciscus, Editor-in-Chief HCV Snapshots Lucinda K. Porter, RN Liver Transplantation: An Overview Liz Highleyman HealthWise: The Power Is in Our Hands Lucinda K. Porter, RN <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> Don't forget to keep checking out our blog <http://hcvadvocate.blogspot.com/> for more about the most recent news stories. <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Sincerely, <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Join us on Twitter - <http://twitter.com/HCVAdvocate> . <http://twitter.com/HCVAdvocate> Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.org <http://www.hcvadvocate.org> Editor-in-Chief, HBV Advocate www.hbvadvocate.org <http://www.hbvadvocate.org> <http://www.hbvadvocate.org> .. <http://www.hbvadvocate.org> **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> **To receive the eblast in your email inbox simply send an e-mail to: listserv@... <javascript:parent.gMail.openComposeWindow('listserv@...')> with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. <javascript:parent.gMail.openComposeWindow('listserv@...')> .. <javascript:parent.gMail.openComposeWindow('listserv@...')> <http://www.hcvadvocate.org/index.asp> HBV & raquo; HBV Journal Review <http://www.hbvadvocate.org/news/HBJ8.2.htm> <http://www.hbvadvocate.org/news/HBJ8.2.htm> & raquo; HBV Factsheets <http://www.hbvadvocate.org/hepatitis/factsheets.asp> <http://www.hbvadvocate.org/hepatitis/factsheets.asp> & raquo; HBV & HCV Advocate Hepatitis Blog <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> & raquo; Stay connected with all the late-breaking news on hepatitis B <http://twitter.com/HBVAdvocate> -Join us on Twitter <http://twitter.com/HBVAdvocate> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 1, 2011 Report Share Posted March 1, 2011 -------- Begin forwarded message -------- Subject: HCV Advocate Email Alert Date: 3/1/11 11:53:54 AM From: " www.hcvadvocate.org " emailalert@... March 1, 2011 HCV & raquo; February Newsletter <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> & raquo; HCV Fact Sheets <http://www.hcvadvocate.org/hepatitis/factsheets.asp> <http://www.hcvadvocate.org/hepatitis/factsheets.asp> & raquo; Educational Materials <http://www.hcvadvocate.org/hepatitis/materials.asp> <http://www.hcvadvocate.org/hepatitis/materials.asp> & raquo; HCSP Streaming Videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> Hello: <http://www.hcvadvocate.org/hepatitis/training_resources.asp> I am Kukka, HBV Project Manager with the Hepatitis C Support Project (HCSP). Every month, I scour dozens of medical journals to find out the latest about hepatitis B treatment and disease progression and prevention. The type of reports I look for can range from a study on a successful community approach to screening and immunizing immigrants against hepatitis B, to an analysis that identifies which patients would benefit most from pegylated interferon. <http://www.hcvadvocate.org/hepatitis/training_resources.asp> 1. In this month's HBV Journal Review <http://www.hbvadvocate.org/news/HBJ8.3.htm> , posted at the HCSP HBV dedicated site, the HBV Advocate <http://www.hbvadvocate.org> , readers can learn about how lives and health care dollars are saved when treatment begins early, how in vitro fertilization can transmit HBV, and how doctors lack clear guidelines about when it's safe for patients to stop antiviral treatment. <http://www.hbvadvocate.org> <http://www.hbvadvocate.org> 2. Also... be sure to check out the HCV Advocate <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> Newsletter <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> for the month of March, 2011. <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> In This Issue: <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> HCV Protease Inhibitor-TMC435: Phase 3 Studies Alan Franciscus, Editor-in-Chief Hepatitis C in Egypt Alan Franciscus, Editor-in-Chief HCV Snapshots Lucinda K. Porter, RN Liver Transplantation: An Overview Liz Highleyman HealthWise: The Power Is in Our Hands Lucinda K. Porter, RN <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> Don't forget to keep checking out our blog <http://hcvadvocate.blogspot.com/> for more about the most recent news stories. <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Sincerely, <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Join us on Twitter - <http://twitter.com/HCVAdvocate> . <http://twitter.com/HCVAdvocate> Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.org <http://www.hcvadvocate.org> Editor-in-Chief, HBV Advocate www.hbvadvocate.org <http://www.hbvadvocate.org> <http://www.hbvadvocate.org> .. <http://www.hbvadvocate.org> **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> **To receive the eblast in your email inbox simply send an e-mail to: listserv@... <javascript:parent.gMail.openComposeWindow('listserv@...')> with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. <javascript:parent.gMail.openComposeWindow('listserv@...')> .. <javascript:parent.gMail.openComposeWindow('listserv@...')> <http://www.hcvadvocate.org/index.asp> HBV & raquo; HBV Journal Review <http://www.hbvadvocate.org/news/HBJ8.2.htm> <http://www.hbvadvocate.org/news/HBJ8.2.htm> & raquo; HBV Factsheets <http://www.hbvadvocate.org/hepatitis/factsheets.asp> <http://www.hbvadvocate.org/hepatitis/factsheets.asp> & raquo; HBV & HCV Advocate Hepatitis Blog <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> & raquo; Stay connected with all the late-breaking news on hepatitis B <http://twitter.com/HBVAdvocate> -Join us on Twitter <http://twitter.com/HBVAdvocate> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 1, 2011 Report Share Posted March 1, 2011 -------- Begin forwarded message -------- Subject: HCV Advocate Email Alert Date: 3/1/11 11:53:54 AM From: " www.hcvadvocate.org " emailalert@... March 1, 2011 HCV & raquo; February Newsletter <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0211.html> & raquo; HCV Fact Sheets <http://www.hcvadvocate.org/hepatitis/factsheets.asp> <http://www.hcvadvocate.org/hepatitis/factsheets.asp> & raquo; Educational Materials <http://www.hcvadvocate.org/hepatitis/materials.asp> <http://www.hcvadvocate.org/hepatitis/materials.asp> & raquo; HCSP Streaming Videos <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> <http://www.hcvadvocate.org/hepatitis/training_resources.asp> Hello: <http://www.hcvadvocate.org/hepatitis/training_resources.asp> I am Kukka, HBV Project Manager with the Hepatitis C Support Project (HCSP). Every month, I scour dozens of medical journals to find out the latest about hepatitis B treatment and disease progression and prevention. The type of reports I look for can range from a study on a successful community approach to screening and immunizing immigrants against hepatitis B, to an analysis that identifies which patients would benefit most from pegylated interferon. <http://www.hcvadvocate.org/hepatitis/training_resources.asp> 1. In this month's HBV Journal Review <http://www.hbvadvocate.org/news/HBJ8.3.htm> , posted at the HCSP HBV dedicated site, the HBV Advocate <http://www.hbvadvocate.org> , readers can learn about how lives and health care dollars are saved when treatment begins early, how in vitro fertilization can transmit HBV, and how doctors lack clear guidelines about when it's safe for patients to stop antiviral treatment. <http://www.hbvadvocate.org> <http://www.hbvadvocate.org> 2. Also... be sure to check out the HCV Advocate <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> Newsletter <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> for the month of March, 2011. <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> In This Issue: <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> HCV Protease Inhibitor-TMC435: Phase 3 Studies Alan Franciscus, Editor-in-Chief Hepatitis C in Egypt Alan Franciscus, Editor-in-Chief HCV Snapshots Lucinda K. Porter, RN Liver Transplantation: An Overview Liz Highleyman HealthWise: The Power Is in Our Hands Lucinda K. Porter, RN <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> <http://www.hcvadvocate.org/news/newsLetter/2011/advocate0311.html> Don't forget to keep checking out our blog <http://hcvadvocate.blogspot.com/> for more about the most recent news stories. <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Sincerely, <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> Join us on Twitter - <http://twitter.com/HCVAdvocate> . <http://twitter.com/HCVAdvocate> Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.org <http://www.hcvadvocate.org> Editor-in-Chief, HBV Advocate www.hbvadvocate.org <http://www.hbvadvocate.org> <http://www.hbvadvocate.org> .. <http://www.hbvadvocate.org> **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> <javascript:parent.gMail.openComposeWindow('alanfranciscus@...')> **To receive the eblast in your email inbox simply send an e-mail to: listserv@... <javascript:parent.gMail.openComposeWindow('listserv@...')> with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. <javascript:parent.gMail.openComposeWindow('listserv@...')> .. <javascript:parent.gMail.openComposeWindow('listserv@...')> <http://www.hcvadvocate.org/index.asp> HBV & raquo; HBV Journal Review <http://www.hbvadvocate.org/news/HBJ8.2.htm> <http://www.hbvadvocate.org/news/HBJ8.2.htm> & raquo; HBV Factsheets <http://www.hbvadvocate.org/hepatitis/factsheets.asp> <http://www.hbvadvocate.org/hepatitis/factsheets.asp> & raquo; HBV & HCV Advocate Hepatitis Blog <http://hcvadvocate.blogspot.com/> <http://hcvadvocate.blogspot.com/> & raquo; Stay connected with all the late-breaking news on hepatitis B <http://twitter.com/HBVAdvocate> -Join us on Twitter <http://twitter.com/HBVAdvocate> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.